The Cardio-Oncology program at Smilow Cancer Hospital at Yale-New Haven is a combined inpatient and outpatient consultative service that addresses the cardiovascular complications of cancer and its treatment.


The program was launched in response to emerging data that indicates that newly developed drugs for cancer treatment are having unanticipated side effects. Drugs such as Herceptin, which is very effective in the treatment of breast cancer, can have cardio-toxic side effects that are just beginning to be understood and researched.

Led by cardiologists with expertise in cardiac imaging, cardio-oncology team members work closely with Smilow oncologists to ensure patients can continue essential cancer treatment while maximizing the protection of their hearts.

Our Physicians

Use our online tool to find a doctor

Cancer Support Groups

Yale Cancer Center
Magnet Recognition Best Hospitals 2012-2013
Visit Closer to Free